Hepatic Effects: Instruct patients to promptly stop taking alogliptin and pioglitazone tablets and seek immediate medical advice if they experience signs or symptoms of liver injury (e.g., unexplained nausea, vomiting, abdominal pain, fatigue, anorexia or dark urine) [see Warnings and Precautions (5.4)]
Blue Cross Blue Shield will review this information as part of their decision-making process
Prioritizing calorie-dense, nutrient-rich foods at every meal
Another investigation involving 7.5 grams of allulose administered before a meal showed trends toward elevated GLP-1 concentrations, but these findings did not consistently reach statistical significance across all measured time points
In large studies, people on the high-dose injection lost about 15% to 20% of their body weight
doi: 10.4161/cbt.9.1.10392